From: The evolution and future of diabetic kidney disease research: a bibliometric analysis
Subcategory | Description | Article Number | CT (total) | % total |
---|---|---|---|---|
Experimental studies (EG) n = 65 | Studies on mechanisms, metabolomics, transcriptome, genetics, potential molecular biomarkers | 5, 6, 12, 13, 19–25, 28–31, 33, 34, 37–40, 42, 43, 45, 48, 49, 51, 53–57, 59–61, 63, 65, 67–74, 77–79, 81–85, 87–92, 94–97, 99, 100 | 19,280 | 49.62 |
Clinical studies (CS) n = 26 | Clinical trials, observational studies | 1–3, 7–10, 14, 15, 17, 18, 27, 32, 35, 36, 41, 44, 50, 52, 62, 64, 66, 75, 80, 86, 93 | 16,144 | 41.55 |
Epidemiological studies (ES) n = 7 | Studies on prevalence, risk factors, outcomes | 4, 16, 26, 46, 58, 76, 98 | 2603 | 6.70 |
Pathological and pathophysiological studies (PP) n = 2 | Studies on pathology and pathophysiology | 11, 47 | 828 | 2.13 |